These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 487244)

  • 1. Interaction of spironolactone with rat skin androgen receptor.
    Boisselle A; Dionne FT; Tremblay RR
    Can J Biochem; 1979 Jul; 57(7):1042-6. PubMed ID: 487244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SC 25152: A potent mineralocorticoid antagonist with reduced affinity for the 5 alpha-dihydrotestosterone receptor of human and rat prostate.
    Cutler GB; Pita JC; Rifka SM; Menard RH; Sauer MA; Loriaux DL
    J Clin Endocrinol Metab; 1978 Jul; 47(1):171-5. PubMed ID: 263288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Androgen receptor in rat skeletal muscle: characterization and physiological variations.
    Michel G; Baulieu EE
    Endocrinology; 1980 Dec; 107(6):2088-98. PubMed ID: 6968675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytosol androgen receptor (AR) in human skin fibroblasts: characterization of the binding reaction and differentiation from androgen binding molecules of lower affinity.
    Keenan BS; Greger NG; Hedge AM; McNeel RL
    Steroids; 1984 Feb; 43(2):159-78. PubMed ID: 6523537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antiandrogenic effects of delta 1-testolactone (Teslac) in vivo in rats and in vitro in human cultured fibroblasts, rat mammary carcinoma cells, and rat prostate cytosol.
    Vigersky RA; Mozingo D; Eil C; Purohit V; Bruton J
    Endocrinology; 1982 Jan; 110(1):214-9. PubMed ID: 7053985
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of the androgen and glucocorticoid receptors in rat and mouse skeletal muscle cytosol.
    Dahlberg E; Snochowski M; Gustafsson JA
    Endocrinology; 1981 Apr; 108(4):1431-40. PubMed ID: 6970661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
    Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
    Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of human skin fibroblasts to obtain potency estimates of drug binding to androgen receptors.
    Eil C; Edelson SK
    J Clin Endocrinol Metab; 1984 Jul; 59(1):51-5. PubMed ID: 6725525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Marihuana inhibits dihydrotestosterone binding to the androgen receptor.
    Purohit V; Ahluwahlia BS; Vigersky RA
    Endocrinology; 1980 Sep; 107(3):848-50. PubMed ID: 6249575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antagonist action of dihydroprogesterone on the formation of the specific dihydrotestosterone-cytoplasmic receptor complex in rat ventral prostate.
    Wright F; Kirchhoffer MO; Mauvais-Jarvis P
    J Steroid Biochem; 1979 Apr; 10(4):419-22. PubMed ID: 449318
    [No Abstract]   [Full Text] [Related]  

  • 11. Interaction of digitalis and spironolactone with human sex steroid receptors.
    Rifka SM; Pita JC; Vigersky RA; Wilson YA; Loriaux DL
    J Clin Endocrinol Metab; 1978 Feb; 46(2):338-44. PubMed ID: 86546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a new radioactive ligand, 7 alpha, 17 alpha-dimethyl[17 alpha-methyl 3H]19-nortestosterone for the estimation of androgen receptors in rat liver cytosol.
    Bannister P; Sheridan P; Losowsky MS
    J Steroid Biochem; 1985 Jul; 23(1):121-3. PubMed ID: 4040590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyproterone acetate prevents translocation of the androgen receptor in the rat prostate.
    Brinkmann AO; Lindh LM; Breedveld DI; Mulder E; Van Der Molen HJ
    Mol Cell Endocrinol; 1983 Oct; 32(2-3):117-29. PubMed ID: 6227511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and hormonal control of the androgen receptor in the hamster sebaceous glands.
    Bonne C; Raynaud JP
    J Invest Dermatol; 1977 Apr; 68(4):215-20. PubMed ID: 845456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of spironolactone and digitalis with the 5 alpha-dihydrotestosterone (DHT) receptor of rat ventral prostate.
    Pita JC; Lippman ME; Thompson EB; Loriaux DL
    Endocrinology; 1975 Dec; 97(6):1521-7. PubMed ID: 173527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of replenishment of nuclear androgen receptor in rat ventral prostate.
    Van Doorn E; Bruchovsky N
    Biochem J; 1978 Jul; 174(1):9-16. PubMed ID: 697767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear acceptor sites for androgen-receptor complexes in seminal-vesicle epithelium.
    Weinberger MJ; Veneziale CM
    Biochem J; 1980 Oct; 192(1):41-7. PubMed ID: 7305910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vivo metabolites of spironolactone and potassium canrenoate: determination of potential anti-androgenic activity by a mouse kidney cytosol receptor assay.
    Armanini D; Karbowiak I; Goi A; Mantero F; Funder JW
    Clin Endocrinol (Oxf); 1985 Oct; 23(4):341-7. PubMed ID: 4064345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the cytosol androgen receptor of the human prostate.
    Wilbert DM; Griffin JE; Wilson JD
    J Clin Endocrinol Metab; 1983 Jan; 56(1):113-20. PubMed ID: 6183286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear androgen binding sites in the male rat. I. Unoccupied sites in the prostate.
    Chapman JC; Frankel AI
    J Steroid Biochem; 1984 Jun; 20(6A):1285-94. PubMed ID: 6748644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.